LOS ANGELES, Dec. 27, 2011 /PRNewswire/ -- Decision Diagnostics Corp., formerly known as InstaCare Corp., (OTCQB: ISCRD), a leading provider of prescription diagnostics, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that its previously announced 10% Stock Dividend will be Ex-Dividend to all shareholders of record on December 28, 2011. The Dividend payment date will be December 30, 2011.
Mr. Berman, CFO and Secretary commented, "the stock Dividend is designed to enhance the visibility of the company, improve liquidity, and reward our loyal shareholders. This Dividend and the changes to the company's capital structure are part of an effort to qualify to have our common stock to be listed on a national exchange, with the goal of applying to the NASDAQ Bx exchange in 2012."
Decision Diagnostics also announced that the company acquired another small engineering oriented company, Sensor Concepts, LLC, an electro-chemistry concepts company. In addition, the company announced that they have formulated a patent enforcement strategy to coincide with the expected near term grant of the patent for the company's MD@Hand technologies.
Mr. Berman continued, "the Board will continue to evaluate other acquisitions that would add to the company's depth in the at-home diagnostics channel, while we conclude the FDA 510k approval process for Shasta Genstrip. We will have more to say about our new patent enforcement strategies in the coming days."
For more information about Decision Diagnostics Corp. and its revolutionary MD@Hand cell phone centric technologies, and, Pharma Tech Solutions, Inc. and its Shasta Genstrip, please visit the Decision Diagnostics web site
|SOURCE Decision Diagnostics Corp.|
Copyright©2010 PR Newswire.
All rights reserved